DOPPLER SONOGRAPHY EVALUATION OF SUPERIOR MESENTERIC-ARTERY FLOW TO ASSESS CROHNS-DISEASE ACTIVITY - CORRELATION WITH CLINICAL-EVALUATION, CROHNS-DISEASE ACTIVITY INDEX, AND ALPHA(1)-ANTITRYPSIN CLEARANCE IN FECES
Ja. Vanoostayen et al., DOPPLER SONOGRAPHY EVALUATION OF SUPERIOR MESENTERIC-ARTERY FLOW TO ASSESS CROHNS-DISEASE ACTIVITY - CORRELATION WITH CLINICAL-EVALUATION, CROHNS-DISEASE ACTIVITY INDEX, AND ALPHA(1)-ANTITRYPSIN CLEARANCE IN FECES, American journal of roentgenology, 168(2), 1997, pp. 429-433
OBJECTIVE. This study was undertaken to investigate the value of Doppl
er flow measurements of the superior mesenteric artery (SMA) as a mark
er for disease activity in patients with Crohn's disease. SUBJECTS AND
METHODS. Duplex Doppler sonography measurements of SMA blood flow vol
ume were obtained in 29 consecutive patients with suspected Crohn's di
sease. We prospectively sought a correlation between the independent a
ssessment of Doppler flow measurements and markers for disease activit
y: Crohn's disease activity index and fecal alpha(1)-antitrypsin clear
ance and our reference standard based on clinical history, physical ex
amination, laboratory values, endoscopy, surgery, and follow-up. RESUL
TS. In 27 of 29 patients, adequate measurements of SMA blood flow were
obtained. In 15 patients no disease activity was judged to be present
or no Crohn's disease (n = 2) was found at follow-up (group 1). In 12
patients, activity of Crohn's disease was diagnosed (group 2) on the
basis of the reference standard. In group 2 the Doppler SMA blood flow
values were significantly higher (p < .05) than those for group 1 (82
6 +/- 407 ml/min ver sus 323 +/- 103 ml/min). Of the other parameters
investigated, only the alpha(1)-antitrypsin value correlated with the
reference standard but to a lesser degree than the values for SMA bloo
d flow measurement. CONCLUSION. This prospective study shows that SMA
Doppler blood flow measurements can be used to assess disease activity
in patients with Crohn's disease. This approach may be of value in th
e diagnosis and follow-up of patients with Crohn's disease, providing
directly available, quantifiable, noninvasive information on disease a
ctivity.